FDA inspection
BRI Institutional Review Board, Inc.: FDA inspection ending Feb 15, 2002
FDA inspection 205961 · No Action Indicated (NAI) · Houston, TX
Key facts
| Inspection ID | 205961 |
|---|---|
| Firm | BRI Institutional Review Board, Inc. |
| FEI number | 1000220451 |
| Address | 9432 Katy Fwy Ste 370 |
| City | Houston |
| State | TX |
| ZIP | 77055-6330 |
| Fiscal year | 2002 |
| Inspection end date | Feb 15, 2002 |
| Classification | No Action Indicated (NAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data